rebeccamycin has been researched along with nb 506 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anizon, F; Bailly, C; Chaires, JB; Prudhomme, M; Qu, X; Riou, JF | 1 |
| Bailly, C; Carrasco, C; Hamy, F; Prudhomme, M; Rubin, E; Saleem, A; Vezin, H | 1 |
2 other study(ies) available for rebeccamycin and nb 506
| Article | Year |
|---|---|
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
Topics: Amino Sugars; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Base Sequence; Binding Sites; Binding, Competitive; Carbazoles; DNA; Glucosides; Indoles; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1999 |
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
Topics: Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Camptothecin; Carbazoles; DNA Damage; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosides; Humans; Indoles; Intercalating Agents; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Recombinant Proteins; Serine; Topoisomerase I Inhibitors | 1999 |